Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$510.08 +6.83 (+1.36%)
At close: Oct 9, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Net of Acquisitions & Divestments (2009 - 2019)

Updated

Analysis

Vertex Pharmaceuticals (VRTX) Net of Acquisitions & Divestments (2009 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn -8.75 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 17.24 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn -
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn -
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 85.00 Mn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -11.21 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -908.38 Mn
Mar 31, 2009 -87.42 Mn
API Access

Vertex Pharmaceuticals Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=VRTX&period=max&api_key=YOUR_API_KEY